Clinical Trial Update: ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for ELVN-002 with trastuzumab (± chemotherapy) in HER2-positive breast cancer, gastric cancer, and colorectal cancer; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• ELVN-002
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Enliven Therapeutics | Conditions: HER2-positive Breast Cancer, HER2-positive Gastric Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING